Bifidobacterium breve – B632 (DSM 24706)

Overview

Inhibition of pathogens E. coli and Enterobacteriaceae

Scientific reference(s)

Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains (LP01, LP02, LR04, LR06, LPS01, LDD01, BR03, B632). J Clin Gastroenterol. 2012; 46 Suppl:S29-32.

Simone M. et al. The Probiotic Bifidobacterium breve B632 Inhibited the Growth of Enterobacteriaceae within Colicky Infant Microbiota Cultures. BioMed Research International 1-6, 2014.

Additional info

Therapeutical area(s)

Urogenital system

Functionality

Antipathogenic activity

Age/Gender

Adults

Search strain on Pubmed

MicrobiomeHUB is a space that brings together the companies of the microbiome industry

Brought to you by Clorofilla Scientific Publishing

This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.

Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963

Read MicrobiomeHUB’s Privacy Policy